These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26111092)

  • 1. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats.
    Studer ME; Martin CL; Stiles J
    Am J Vet Res; 2000 Oct; 61(10):1220-4. PubMed ID: 11039551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
    Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
    Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
    Kashiwagi K; Tsukahara S
    Br J Ophthalmol; 2003 Mar; 87(3):297-301. PubMed ID: 12598441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical administration of 0.005% latanoprost solution on eyes of clinically normal horses.
    Willis AM; Diehl KA; Hoshaw-Woodard S; Kobayashi I; Vitucci MP; Schmall LM
    Am J Vet Res; 2001 Dec; 62(12):1945-51. PubMed ID: 11763186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
    Tofflemire K; Whitley EM; Allbaugh R; Ben-Shlomo G; Griggs A; Strong T; Whitley RD
    Vet Ophthalmol; 2017 Sep; 20(5):398-404. PubMed ID: 27791324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
    Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
    Liu JH; Kripke DF; Weinreb RN
    Am J Ophthalmol; 2004 Sep; 138(3):389-95. PubMed ID: 15364220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of latanoprost and latanoprostene bunod on intraocular pressure and pupil size in ophthalmologically normal Beagle dogs.
    Desai SJ; Pumphrey SA; Koethe B
    Vet Ophthalmol; 2022 Jul; 25(4):282-290. PubMed ID: 35247289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats.
    McDonald JE; Kiland JA; Kaufman PL; Bentley E; Ellinwood NM; McLellan GJ
    Vet Ophthalmol; 2016 Jul; 19 Suppl 1(Suppl 1):13-23. PubMed ID: 26183373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of latanoprost when stored at room temperature.
    Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
    Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs.
    Sarchahi AA; Abbasi N; Gholipour MA
    Vet Ophthalmol; 2012 Mar; 15 Suppl 1():64-70. PubMed ID: 22050700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
    Serle JB; Podos SM; Kitazawa Y; Wang RF
    Jpn J Ophthalmol; 1998; 42(2):95-100. PubMed ID: 9587840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical ophthalmic administration of 0.005% latanoprost solution on aqueous humor flow rate and intraocular pressure in ophthalmologically normal adult Beagles.
    Fentiman KE; Rankin AJ; Meekins JM; Roush JK
    Am J Vet Res; 2019 May; 80(5):498-504. PubMed ID: 31034278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T; Aihara M; Narumiya S; Araie M
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.